Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified: Clinical Trials

5 trials for Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed, 1 suspended, 1 withdrawn. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Terminated 2, Completed 1, Suspended 1, Withdrawn 1
Phase 21Suspended 1

Follow Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified: new trials by email Literature Review of Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified trials Research Report on Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma
Vevoctadekin, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Phase 1 / Phase 2SuspendedFred Hutchinson Cancer Center332025-12-272026-09-11
Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell Lymphoma
Autologous Hematopoietic Stem Cell Transplantation, Carmustine, Cytarabine - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Phase 1WithdrawnFred Hutchinson Cancer Center2023-04-012023-01-13
NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
Cyclophosphamide, Fludarabine, Lisocabtagene Maraleucel - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Phase 1CompletedFred Hutchinson Cancer Center272022-12-082026-09-21
CD19-Specific T Cells Post AlloSCT
Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T Cells, Cyclophosphamide, Fludarabine - B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged, Recurrent B Acute Lymphoblastic Leukemia
Phase 1TerminatedM.D. Anderson Cancer Center42020-06-262021-06-02
huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia
Autologous Human Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T-lymphocytes, Cyclophosphamide, Fludarabine - Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma
Phase 1TerminatedFred Hutchinson Cancer Center552017-11-032024-04-10

Narrower conditions

Lymphoma, Large B-Cell, Diffuse (5)  ·  Burkitt Lymphoma (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Hemic and Lymphatic Diseases (5)  ·  Immune System Diseases (5)  ·  Immunoproliferative Disorders (5)  ·  Lymphatic Diseases (5)  ·  Lymphoma (5)  ·  Lymphoproliferative Disorders (5)  ·  Neoplasms (5)  ·  Neoplasms by Histologic Type (5)  ·  Lymphoma, B-Cell (4)  ·  Lymphoma, Non-Hodgkin (4)  ·  DNA Virus Infections (2)  ·  Epstein-Barr Virus Infections (2)  ·  Hematologic Diseases (2)  ·  Herpesviridae Infections (2)  ·  Infections (2)

Interventions

Cyclophosphamide (3)  ·  fludarabine (3)  ·  Biopsy (2)  ·  Leukapheresis (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Phantoms, Imaging (2)  ·  Spinal Puncture (2)  ·  X-Rays (2)  ·  Carmustine (1)  ·  Cytarabine (1)  ·  Etoposide (1)  ·  Melphalan (1)  ·  NKTR-255 (1)  ·  Stem Cell Transplantation (1)  ·  loncastuximab tesirine (1)

Sponsors

Fred Hutchinson Cancer Center (4)  ·  M.D. Anderson Cancer Center (1)

Countries

United States (5)

Top investigators

Alexandre Hirayama (1)  ·  Alexandre V. Hirayama, MD (1)  ·  Jordan Gauthier (1)  ·  Partow Kebriaei (1)  ·  Victor Chow (1)

Results publications

PMID 34515338, PMID 39820359